NCT05772039

Brief Summary

There is still a need for the assessment of different minimal intervention strategies and treatments focusing on the prevention and arrest of carious lesions of primary molars The evidence-based clinical practice guideline on non-restorative treatments for cavitated carious lesions advocate the use of silver diammine fluoride biannually for high caries risk patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2022

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 13, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 16, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
Last Updated

March 16, 2023

Status Verified

March 1, 2023

Enrollment Period

1.5 years

First QC Date

February 13, 2023

Last Update Submit

March 5, 2023

Conditions

Keywords

SDFNaF-fTCPchild behaviorpain experienceWong-Baker Faces Pain rating scaleoral health-related quality of lifecaries arrestcaries preventionsilver diammine fluorideminimal intervention dentistryFunctionalized tricalcium phosphateSodium fluoride

Outcome Measures

Primary Outcomes (20)

  • Caries prevalence

    Calculated by the frequency of participants having decayed, missing, filled surfaces of dentition

    Baseline

  • Frequency distribution of caries risk

    Calculated using Caries Risk Assessment questionnaire, which is denoted as low, moderate or high

    Baseline

  • Mean score of oral health impact

    Calculated using Urdu-Early Childhood Oral Health Impact Scale form, the answer for each item is on a 5-point scale. The sum score of answers to the 13 questions can range from 0-52. The impact of oral health on life activities is predicted to be greater with a higher score in the summation which denotes a poorer quality of life.

    Baseline

  • Patient behaviour towards dental treatment

    Calculated using Frankl behaviour rating scale four category which are: definitely negative, negative, positive, definitely positive

    Baseline

  • Mean score of pain experience

    Calculated using Wong Baker Faces Scale on a range of facial expression where 0 denotes no pain, 2, 4, 6 ,8 and 10 denotes the most painful experience

    Baseline

  • Mean value of caries experience

    Calculated by summation of number of decayed, missing and filled surfaces of dentition

    Baseline

  • Extent of selected cavitated carious lesion using ICDAS

    Coded according to ICDAS-2 scoring system code 3: Moderate enamel breakdown, code 4: Moderate underlying dentinal shadow 5: extensive carious lesion extending to dentin without pulpal involvement

    Baseline

  • Extent of selected cavitated carious lesion using FOTI

    Coded using Fiber optic transillumination device corresponding to ICDAS code 3- code 5

    Baseline

  • Changes in the mean score of oral health impact

    Calculated using Urdu-Early Childhood Oral Health Impact Scale form, the answer for each item is on a 5-point scale. The sum score of answers to the 13 questions can range from 0-52. The impact of oral health on life activities is predicted to be greater with a higher score in the summation which denotes a poorer quality of life.

    6 months

  • Changes in the mean score of patient behaviour towards dental treatment

    Calculated using Frankl behaviour rating scale four category which are: definitely negative, negative, positive, definitely positive

    6 months

  • Changes in the mean score of pain experience

    Calculated using Wong Baker Faces Scale on a range of facial expression where 0 denotes no pain, 2, 4, 6 ,8 and 10 denotes the most painful experience

    6 months

  • Changes in the mean value of caries experience

    Calculated by summation of number of decayed, missing and filled surfaces of dentition

    6 months

  • Extent of selected cavitated carious lesion using ICDAS

    Coded according to ICDAS-2 scoring system code 3: Moderate enamel breakdown, code 4: Moderate underlying dentinal shadow 5: extensive carious lesion extending to dentin without pulpal involvement

    6 months

  • Extent of selected cavitated carious lesion using FOTI

    Coded using Fiber optic transillumination device corresponding to ICDAS code 3- code 5

    6 months

  • Changes in the mean score of oral health impact

    Calculated using Urdu-Early Childhood Oral Health Impact Scale form, the answer for each item is on a 5-point scale. The sum score of answers to the 13 questions can range from 0-52. The impact of oral health on life activities is predicted to be greater with a higher score in the summation which denotes a poorer quality of life.

    12 months

  • Changes in the mean score of patient behaviour towards dental treatment

    Calculated using Frankl behaviour rating scale four category which are: definitely negative, negative, positive, definitely positive

    12 months

  • Changes in the mean score of pain experience

    Calculated using Wong Baker Faces Scale on a range of facial expression where 0 denotes no pain, 2, 4, 6 ,8 and 10 denotes the most painful experience

    12 months

  • Changes in the mean value of caries experience

    Calculated by summation of number of decayed, missing and filled surfaces of dentition

    12 months

  • Extent of selected cavitated carious lesion using ICDAS

    Coded according to ICDAS-2 scoring system code 3: Moderate enamel breakdown, code 4: Moderate underlying dentinal shadow 5: extensive carious lesion extending to dentin without pulpal involvement

    12 months

  • Extent of selected cavitated carious lesion using FOTI

    Coded using Fiber optic transillumination device corresponding to ICDAS code 3- code 5

    12 months

Secondary Outcomes (5)

  • Number of participants reporting adverse events

    Baseline

  • Percentage of dropouts

    6 months

  • Number of participants reporting adverse events

    6 months

  • Percentage of dropouts

    12 months

  • Number of participants reporting adverse events

    12 months

Study Arms (6)

Topical application of 38% Silver Diammine Fluoride Solution at Baseline

ACTIVE COMPARATOR

* SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. * 1 drop (0.05 ml) will be dispensed on a plastic container. * 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. * Ultrafine microbrushes will be used to apply varnish.

Drug: Topical application of 38% Silver Diammine Fluoride Solution

Topical application of 38% Silver Diammine Fluoride Solution at 6 months

ACTIVE COMPARATOR

* SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. * 1 drop (0.05 ml) will be dispensed on a plastic container. * 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. * Ultrafine microbrushes will be used to apply varnish.

Drug: Topical application of 38% Silver Diammine Fluoride Solution

Topical application of 38% Silver Diammine Fluoride Solution at 12 months

ACTIVE COMPARATOR

* SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. * 1 drop (0.05 ml) will be dispensed on a plastic container. * 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. * Ultrafine microbrushes will be used to apply varnish.

Drug: Topical application of 38% Silver Diammine Fluoride Solution

Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at baseline

EXPERIMENTAL

* 0.25 ml of the solution will be used which contains 12.5 mg of fluoride. * Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.

Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish

Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 6 months

EXPERIMENTAL

* 0.25 ml of the solution will be used which contains 12.5 mg of fluoride. * Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.

Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish

Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 12 months

EXPERIMENTAL

* 0.25 ml of the solution will be used which contains 12.5 mg of fluoride. * Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.

Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish

Interventions

* Application of petroleum jelly on lips and around the mouth for prevention of temporary silver tattoo. * Before SDF application, the affected area will be thoroughly dried and isolated using the cotton rolls or dri-angle. * Isolation throughout the procedure and following three minutes is considered most desirable. * The varnish should be allowed to be in place for 60 seconds. This is the most critical step in the process. Applied varnish will be dried with gentle flow of compressed air. * SDF will be applied with a microbrush to all carious lesions and to all pits and fissures on posterior (molar) teeth for 60 seconds. * To avoid gingival or mucosal irritation, contact of varnish with any oral tissue other than affected area will be avoided. * If the application time is shorter due to unforeseen reasons reapplication will be considered.

Also known as: Riva Star, 38% Silver Diammine fluoride, SDF, Advanatge Arrest, Saforide
Topical application of 38% Silver Diammine Fluoride Solution at 12 monthsTopical application of 38% Silver Diammine Fluoride Solution at 6 monthsTopical application of 38% Silver Diammine Fluoride Solution at Baseline

* According to manufacturer, Clinpro® White Varnish can be applied to tooth surfaces where plaque is present. A prophylaxis is not required. * The applicator brush provided along is used to thoroughly mix the varnish inside the single-unit dose pack, since components of all sodium fluoride varnishes are separate during storage. * Excessive contact with soft tissue should be avoided. * Only enough varnish to form a thin coating on the desired treatment area should be used. * After application, patient should be instructed to close their mouth to set the varnish. * Rinsing or suctioning immediately after application is not recommended. * The operator might appreciate the formation of a thin coating on the teeth and the patient should be informed that they may feel a thin coating when rubbing the treated area with their tongue.

Also known as: ClinPro White varnish, Sodium fluoride with functionalized tricalcium phosphate, NaF-fTCP
Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 12 monthsTopical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 6 monthsTopical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at baseline

Eligibility Criteria

Age4 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children will be invited to participate in the trial if they fulfil the entire selection criteria as described below:
  • to 6 years-of-age
  • Identification of one or more carious primary molars without involvement of the pulp confirmed by bitewing radiographs
  • Up to three teeth per each participant will be selected for intervention
  • Has normal salivary flow rate
  • Does not consume medications regularly for any medical condition
  • Has not or will not receive any fluoride therapy or relevant dental therapy from other dental sources within the last six months

You may not qualify if:

  • Children will be excluded from the trial if they fulfil any of the following criteria:
  • Presence of any pain, ulceration, fistula/sinus or an abscess
  • Premature hypermobility of carious teeth which can be potentially included in the study
  • History of allergy to any product containing silver compounds
  • Siblings of the participants will not be allowed to participate to ensure any chance of ECOHIS duplication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Crescent Montessori School

Lahore, Punjab Province, 54600, Pakistan

Location

MeSH Terms

Conditions

Dental CariesChild Behavior

Interventions

silver diamine fluorideSodium Fluoride

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic DiseasesBehavior

Intervention Hierarchy (Ancestors)

FluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsSodium CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Anas Imran Arshad, MSc., BDS

    Universiti Sains Malaysia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pragmatic randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 13, 2023

First Posted

March 16, 2023

Study Start

January 18, 2022

Primary Completion

July 15, 2023

Study Completion

August 15, 2023

Last Updated

March 16, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Patient data will only be used for knowledge transfer and personal information of each patient will be kept private and confidential. After performing data analysis and report writing the collected patient data will be securely transferred to hospital archives which are not accessible without proper identification and authorization. Data from the archives will be automatically erased after two years.

Locations